Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
 Blood, 8 January 2009, Vol. 113, No. 2, pp. 396-402.
Prepublished online as a Blood First Edition Paper on October 21, 2008; DOI 10.1182/blood-2008-07-163907.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Erratum (v113,p5368)
Right arrow All Versions of this Article:
blood-2008-07-163907v1
113/2/396    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Inomata, M.
Right arrow Articles by Sawada, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Inomata, M.
Right arrow Articles by Sawada, K.
Related Collections
Right arrow Lymphoid Neoplasia
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

LYMPHOID NEOPLASIA

MicroRNA-17-92 down-regulates expression of distinct targets in different B-cell lymphoma subtypes

Mika Inomata1,*, Hiroyuki Tagawa1,*, Yong-Mei Guo1, Yoshihiro Kameoka1, Naoto Takahashi1, and Kenichi Sawada1

1 Department of Internal Medicine III, Akita University School of Medicine, Akita, Japan

Aberrant overexpression of the miR-17-92 polycistron is strongly associated with B-cell lymphomagenesis. Recent studies have shown that miR-17-92 down-regulates the proapoptotic protein Bim, leading to overexpression of Bcl2, which likely plays a key role in lymphomagenesis. However, the fact that Jeko-1 cells derived from mantle cell lymphoma exhibit both homozygous deletion of BIM and overexpression of miR-17-92 suggests other targets are also involved in B-cell lymphomagenesis. To identify essential target(s) of miR-17-92 in lymphomagenesis, we first transfected miR-17-92 into 2 genetically distinct B-cell lymphoma cell lines: Raji, which overexpress c-Myc, and SUDHL4, which overexpress Bcl2. Raji transfected with miR-17-19b-1 exhibited down-regulated expression of Bim and a slight up-regulation in Bcl2 expression. On the other hand, SUDHL4 transfectants showed aggressive cell growth reflecting facilitated cell cycle progression at the G1 to S transition and decreased expression of CDKN1A mRNA and p21 protein (CDKN1A/p21) that was independent of p53 expression. Conversely, transfection of antisense oligonucleotides against miR-17 and miR-20a into Jeko-1 led to up-regulation of CDKN1A/p21, resulting in decreased cell growth with G1 to S arrest. Thus, CDKN1A/p21 appears to be an essential target of miR-17-92 during B-cell lymphomagenesis, which suggests the miR-17-92 polycistron has distinct targets in different B-cell lymphoma subtypes.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 BloodHome page
Y. Yamanaka, H. Tagawa, N. Takahashi, A. Watanabe, Y.-M. Guo, K. Iwamoto, J. Yamashita, H. Saitoh, Y. Kameoka, N. Shimizu, et al.
Aberrant overexpression of microRNAs activate AKT signaling via down-regulation of tumor suppressors in natural killer-cell lymphoma/leukemia
Blood, October 8, 2009; 114(15): 3265 - 3275.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
E K O Ng, W W S Chong, H Jin, E K Y Lam, V Y Shin, J Yu, T C W Poon, S S M Ng, and J J Y Sung
Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening
Gut, October 1, 2009; 58(10): 1375 - 1381.
[Abstract] [Full Text] [PDF]

Home page
 Hum Reprod UpdateHome page
E. M. C. Ohlsson Teague, C. G. Print, and M. L. Hull
The role of microRNAs in endometriosis and associated reproductive conditions
Hum. Reprod. Update, September 22, 2009; (2009) dmp034v1.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
D. Sampath and W. Plunkett
Response: Context-dependent actions of miR-106b in CLL
Blood, June 18, 2009; 113(25): 6499 - 6500.
[Full Text] [PDF]

Home page
 Cancer Res.Home page
P. A. Northcott, A. Fernandez-L, J. P. Hagan, D. W. Ellison, W. Grajkowska, Y. Gillespie, R. Grundy, T. Van Meter, J. T. Rutka, C. M. Croce, et al.
The miR-17/92 Polycistron Is Up-regulated in Sonic Hedgehog-Driven Medulloblastomas and Induced by N-myc in Sonic Hedgehog-Treated Cerebellar Neural Precursors
Cancer Res., April 15, 2009; 69(8): 3249 - 3255.
[Abstract] [Full Text] [PDF]


click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2009 by American Society of Hematology         Online ISSN: 1528-0020